MSA Team Works Toward Publications

March 16, 2020

MSA has submitted three manuscripts in high impact journals that report the results of pre-clinical experiments evaluating the pharmacokinetics (nasal absorption), pharmacodynamics (efficacy), and safety in support of Bryn Pharma’s goal to bring a cost-effective intranasal delivery system for patients with anaphylaxis to market.

MSA authors include Principals Dr. Kenneth Dretchen Ph.D., Zack Mesa, and Michael Mesa, along with MSA associate Matt Robben Ph.D.

MSA News

Thank You MSA

August 13, 2021 – This summer, I was able to intern for Mesa Science Associates (MSA). During my tireless search…

Read More

Dr. Kenneth Dretchen PhD continues appointment for year 2 as a member of the Pharmaceutical Research and Manufacturers of America (PhRMA) Drug Discovery Research Award Committee

May 2021 This prestigious committee will review grant applications for Pre-doctoral, Post-doctoral and Research Starter Grants dealing with innovative approaches…

Read More

MesaGreen Announces Progress

K9MGP Seizure Program In July 2019, MesaGreen Pharmaceutical (MGP) entered into a research agreement with the University of Minnesota Schools…

Read More